lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: granules pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
granules pharmaceuticals inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70010-207
Product ID
70010-207_40cab3c8-ab54-904d-e063-6294a90a1e8d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA218987
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2025-01-29
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70010207
Hyphenated Format
70010-207
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA218987 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (70010-207-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "40cab3c8-ab54-904d-e063-6294a90a1e8d", "openfda": {"upc": ["0370010211018", "0370010206014", "0370010207011", "0370010209015", "0370010212015", "0370010208018"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["c91c6acf-b68c-4832-a06f-d0fbd6b80457"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (70010-207-01)", "package_ndc": "70010-207-01", "marketing_start_date": "20250129"}], "brand_name": "LISDEXAMFETAMINE DIMESYLATE", "product_id": "70010-207_40cab3c8-ab54-904d-e063-6294a90a1e8d", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "70010-207", "dea_schedule": "CII", "generic_name": "LISDEXAMFETAMINE DIMESYLATE", "labeler_name": "Granules Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISDEXAMFETAMINE DIMESYLATE", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA218987", "marketing_category": "ANDA", "marketing_start_date": "20250129", "listing_expiration_date": "20261231"}